LONDON, UK – October 31, 2017 –ÌìÃÀ´«Ã½’s Minnetonka laboratory, formerly Medical Device Testing (MDT), has expanded its A2LA ISO 17025 scope by adding an additional seven test methods to its capabilities.
The new expanded scope will add up to 12 test frames to ÌìÃÀ´«Ã½’s global leading implant testing capacity, resulting in decreased time to market for clients and ultimately improved quality of life for the patient. The test methods address product evaluation testing of hip, knee, spine, and trauma implants. These certifications add to the laboratory’s already impressive list of cardiovascular test methods.
Rick Sluiters, EVP Aerospace, ÌìÃÀ´«Ã½, commented: ‘’We are delighted to add these services to our facility in Minnetonka and further expand our capacity to support our clients. The Minneapolis area is a growth hub for medical devices and Minnetonka’s proximity will supplement our leading medical capabilities in the area including medical packaging, environmental, and EMC testing.
The recent acquisition of Exova has propelled ÌìÃÀ´«Ã½ to become one of the world’s leading providers of testing, inspection and certification services to the international medical device sector. We now offer a broad set of capabilities in engineering, materials, microbiology and chemistry that provide our customers with one stop technology services for medical device development and testing.’’
ÌìÃÀ´«Ã½ Minnetonka is the largest cardiovascular, A2LA accredited, testing facility operating in the USA, with over $6 million invested in commercial fatigue and durability test systems, inspection instruments and test fixturing inventory. The laboratory specializes in pulsatile, axial, and bending fatigue on stents, catheters, and heart valves, as well as neurostimulation devices.
About ÌìÃÀ´«Ã½
In June 2017, ÌìÃÀ´«Ã½ acquired to create one, world-class global testing services partner. Element specializes in providing a comprehensive range of materials and product qualification testing, consulting, certification and calibration services to the global Aerospace; Fire & Building Products; Infrastructure & Environmental; Oil & Gas; and Transportation & Industrials sectors.
ÌìÃÀ´«Ã½’s expanded network of 6,200 Engaged Experts operate out of nearly 200 laboratories in more than 30 countries and are trusted by organizations to test and advise on the safety, quality, performance and compliance of their products, systems and operations.
Media contacts:
Diana Milford, External Communications Manager
T: +44 (0) 131 333 8052
Devan LaBrash, Pagoda Public Relations
T: +44 (0) 131 556 0770
“The recent acquisition of Exova has propelled ÌìÃÀ´«Ã½ to become one of the world’s leading providers of testing, inspection and certification services to the international medical device sector. ”
Rick Sluiters
EVP, AEROSPACE